Experimental immune therapy generally safe, well-tolerated in women with triple-negat
Early data in a preliminary human study show that an experimental immune system drug is generally safe and well tolerated in women with metastatic, triple-negative breast cancer, a persistently difficult form of the disease to treat.
Linear Mode
